PharmaLundensis AB reported earnings results for the fourth quarter and full year ended December 31, 2021. For the fourth quarter, the company reported net loss was SEK 0.531028 million compared to SEK 0.796219 million a year ago. Basic loss per share from continuing operations was SEK 0.02 compared to SEK 0.03 a year ago.
For the full year, net loss was SEK 2.61 million compared to SEK 3.2 million a year ago. Basic loss per share from continuing operations was SEK 0.09 compared to SEK 0.13 a year ago.